Africa (WHO region) vs Mauritius: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Mauritius
100.0%
in 2024
Africa (WHO region) rank
2nd
Mauritius rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Mauritius
How they compare
Mauritius currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 4 times across 22 shared years of data; in 2003 it was Mauritius ahead.
Africa (WHO region) ranks 2nd and Mauritius ranks 1st of 11 groups.
Mauritius has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.9% | 72.0% | 41.1% | Mauritius |
| 2010s | 74.3% | 86.2% | 11.9% | Mauritius |
| 2020s | 93.2% | 100.0% | 6.8% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Mauritius?
- Mauritius, at 100.0% against 96.0% in Africa (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Mauritius?
- 4.0%, with Mauritius ahead.
- How many years of comparable data are there for Africa (WHO region) and Mauritius?
- 22 years are reported by both, from 2003 to 2024.
- How do Africa (WHO region) and Mauritius rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Mauritius ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.